These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 3914804)
1. Comparison of insulin regimens in the therapy of type 1 diabetes. Pelkonen R; Koivisto V; Mustajoki P Acta Endocrinol Suppl (Copenh); 1985; 272():49-55. PubMed ID: 3914804 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting. Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467 [TBL] [Abstract][Full Text] [Related]
3. Treatment options for insulin-dependent diabetes mellitus: a comparison of the artificial endocrine pancreas, continuous subcutaneous insulin infusion, and multiple daily insulin injections. Rizza RA Mayo Clin Proc; 1986 Oct; 61(10):796-805. PubMed ID: 3091967 [TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation. Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C; BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112 [TBL] [Abstract][Full Text] [Related]
5. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Bode BW Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065 [TBL] [Abstract][Full Text] [Related]
6. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM. Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173 [TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons. Thabit H; Hovorka R Expert Opin Drug Deliv; 2016; 13(3):389-400. PubMed ID: 26618219 [TBL] [Abstract][Full Text] [Related]
8. Short-term subcutaneous insulin infusion in diabetic children. Comparison with three daily insulin injections. Meschi F; Beccaria L; Vanini R; Szulc M; Chiumello G Acta Diabetol Lat; 1982; 19(4):371-5. PubMed ID: 6758461 [TBL] [Abstract][Full Text] [Related]
9. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. Roze S; Valentine WJ; Zakrzewska KE; Palmer AJ Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855 [TBL] [Abstract][Full Text] [Related]
10. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion. Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726 [TBL] [Abstract][Full Text] [Related]
11. Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insulin-dependent diabetics. Haakens K; Hanssen KF; Dahl-Jørgensen K; Vaaler S; Torjesen P; Try K Scand J Clin Lab Invest; 1989 Nov; 49(7):653-9. PubMed ID: 2692136 [TBL] [Abstract][Full Text] [Related]
12. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy. Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389 [TBL] [Abstract][Full Text] [Related]
13. Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): a cross-sectional cohort study. Schreiver C; Jacoby U; Watzer B; Thomas A; Haffner D; Fischer DC Clin Endocrinol (Oxf); 2013 Nov; 79(5):641-7. PubMed ID: 23134485 [TBL] [Abstract][Full Text] [Related]
14. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Pickup JC; Sutton AJ Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063 [TBL] [Abstract][Full Text] [Related]
15. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459 [TBL] [Abstract][Full Text] [Related]
16. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480 [TBL] [Abstract][Full Text] [Related]
17. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen. Saurbrey N; Arnold-Larsen S; Møller-Jensen B; Kühl C Diabet Med; 1988 Mar; 5(2):150-3. PubMed ID: 2964981 [TBL] [Abstract][Full Text] [Related]
18. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. ; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210 [TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective. St Charles M; Lynch P; Graham C; Minshall ME Value Health; 2009; 12(5):674-86. PubMed ID: 19171006 [TBL] [Abstract][Full Text] [Related]
20. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues. Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]